- Home
- PAVM
PAVM
PAVmed Inc.
as 10-28-2025 9:38am EST
PAVmed Inc is a multi-product, commercial-stage medical technology company organized to advance a broad pipeline of medical technologies from concept to commercialization. The company operates in a single segment as a medical technology company, with the following lines of business: Diagnostics, Medical Devices, and Digital Health. Its products are EsoGuard, esocheck, and the Veris Cancer Care Platform.
| Founded: | 2014 | Country: | United States |
| Employees: | N/A | City: | NEW YORK |
| Market Cap: | 9.4M | IPO Year: | 2016 |
| Target Price: | $20.00 | AVG Volume (30 days): | 713.7K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 1 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | 0.83 | EPS Growth: | N/A |
| 52 Week Low/High: | $0.30 - $1.25 | Next Earning Date: | 11-12-2025 |
| Revenue: | $1,020,000 | Revenue Growth: | -73.36% |
| Revenue Growth (this year): | -95.01% | Revenue Growth (next year): | 234.47% |
Latest PAVmed Inc. News
PAVM Breaking Stock News: Dive into PAVM Ticker-Specific Updates for Smart Investing
PR Newswire
13 days ago
Lucid Diagnostics to Participate in the 2025 Maxim Growth Summit
Zacks
18 days ago
PAVmed (PAVM) Upgraded to Strong Buy: Here's Why
PR Newswire
21 days ago
PAVmed Subsidiary, Veris Health and The Ohio State University Comprehensive Cancer Center Launch Commercial Phase of Strategic Partnership Agreement
PR Newswire
2 months ago
Lucid Diagnostics Announces Closing of Public Offering of Common Stock
PR Newswire
2 months ago
Lucid Diagnostics Announces Pricing of Public Offering of Common Stock
PR Newswire
2 months ago
Lucid Diagnostics Announces Proposed Public Offering of Common Stock
PR Newswire
2 months ago
Lucid Diagnostics Provides Business Update and Reports Second Quarter 2025 Financial Results
PR Newswire
4 months ago
PAVmed Subsidiary Veris Health Completes $2.5 Million Direct Equity Financing
Compare PAVM vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "PAVM PAVmed Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.